Promise and Challenge of β‑Lactone Electrophiles to Target Aspartate 12 of Mutant KRAS<sup>G12D</sup>
The clinical success of covalent KRAS<sup>G12C</sup> inhibition prompts further expansion of the concept to target non-cysteine oncogenic mutation sites as in KRAS<sup>G12D</sup>. This endeavor was hampered by the lack of suitable electrophiles for the selective, covalent eng...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | , , , , , , , , , , , , , , , , , , , , , , , , |
| Published: |
2025
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|